Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03796806
1. Assess validity of methods involved in molecular studies of the skin in inflammatory skin disease 2. Assess feasibility of methods for grafting fresh human skin (normal and diseased with inflammatory skin disease) onto an established xenograft murine model.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
The use of fixed tissue specimens for research studies is attractive, because a large number of relevant specimens can be collected quickly from tissue registry. There is a current lack of knowledge regarding to what extent formalin fixation alters the identification of proteins in the skin with inflammatory dermatoses. This information would be important to assess when determining the limitations (or potentially lack thereof) of using fixed specimens in research.
Collaborators have successfully developed a murine model that can accept human skin xenografts. While those investigators have successfully demonstrated transplantation of healthy skin onto mice, it is unknown whether skin affected by inflammatory disease can be transplanted and, if so, whether the inflammatory skin disease remains, whether it spreads to involve host skin, or whether it resolves. Determining feasibility of transplanting inflamed human skin using this model, as well as observing the course of this inflammation, are the next steps in advancing this potentially invaluable research modality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 months
Identification and quantification of proteins as obtained by liquid chromatography-mass spectrometry methods using fresh and formalin-fixed-paraffin-embedded tissue. Mass spectrometry data will be matched against a composite protein sequence database using the MyriMatch search engine and IDPicker will filter protein identification at 2% false discovery rate. QuasiTel software will process the spectral count data for the identification of differentially expressed proteins.
Time frame: 8 months
Viability of diseased human graft into an established murine xenograft model by visual inspection and microscopic analysis.
Time frame: 8 months
Assessment of inflammation around graft and elsewhere in the host by visual inspection and microscopic analysis.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07570706
Lichen Planus, Lichenoid Eruptions
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT00341497
Head and Neck Neoplasms, Leukoplakia
San Francisco, California, United States
View Trial DetailsNCT02761122
Lichen Planus, Lichenoid Eruptions
Besançon, France
View Trial DetailsNCT04697563
Lichen Planus, Lichen Sclerosus Et Atrophicus
Graz, Austria
View Trial Details